Abstract
Entrectinib (Rozlytrek(R)) is an orally active, CNS-penetrant, small-molecule, selective inhibitor of the tropomyosin receptor tyrosine kinases TRKA/B......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
